Apellis Pharmaceuticals Inc (APLS)
30.77
+3.02
(+10.88%)
USD |
NASDAQ |
Nov 22, 16:00
30.76
-0.01
(-0.03%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Return Price: 30.77 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 30.77 |
November 21, 2024 | 27.75 |
November 20, 2024 | 27.49 |
November 19, 2024 | 28.99 |
November 18, 2024 | 26.18 |
November 15, 2024 | 26.27 |
November 14, 2024 | 28.06 |
November 13, 2024 | 28.25 |
November 12, 2024 | 29.26 |
November 11, 2024 | 29.58 |
November 08, 2024 | 29.98 |
November 07, 2024 | 28.74 |
November 06, 2024 | 28.83 |
November 05, 2024 | 28.08 |
November 04, 2024 | 28.56 |
November 01, 2024 | 27.98 |
October 31, 2024 | 27.26 |
October 30, 2024 | 27.71 |
October 29, 2024 | 27.41 |
October 28, 2024 | 27.34 |
October 25, 2024 | 26.68 |
October 24, 2024 | 27.58 |
October 23, 2024 | 26.98 |
October 22, 2024 | 27.60 |
October 21, 2024 | 26.88 |
Date | Value |
---|---|
October 18, 2024 | 28.00 |
October 17, 2024 | 27.92 |
October 16, 2024 | 27.95 |
October 15, 2024 | 27.95 |
October 14, 2024 | 27.38 |
October 11, 2024 | 27.14 |
October 10, 2024 | 26.67 |
October 09, 2024 | 26.90 |
October 08, 2024 | 27.40 |
October 07, 2024 | 27.45 |
October 04, 2024 | 27.51 |
October 03, 2024 | 28.06 |
October 02, 2024 | 28.48 |
October 01, 2024 | 27.74 |
September 30, 2024 | 28.84 |
September 27, 2024 | 29.47 |
September 26, 2024 | 29.85 |
September 25, 2024 | 30.59 |
September 24, 2024 | 30.75 |
September 23, 2024 | 32.72 |
September 20, 2024 | 32.51 |
September 19, 2024 | 36.73 |
September 18, 2024 | 35.63 |
September 17, 2024 | 35.53 |
September 16, 2024 | 36.31 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
17.91
Minimum
Mar 17 2020
93.31
Maximum
Jun 13 2023
47.36
Average
45.18
Median
Total Return Price Benchmarks
Biomarin Pharmaceutical Inc | 64.26 |
Ionis Pharmaceuticals Inc | 34.01 |
EyePoint Pharmaceuticals Inc | 8.95 |
Cassava Sciences Inc | 26.48 |
Macrogenics Inc | 3.24 |